Ledger.Open graph →
SEC Form D · Amendment · filed April 29, 2019

UBIVAC, INC

Offering
$3.0M
Sold
$1.9M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
PORTLAND, OR
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (12)

Steve A. Buhaly · Portland, ORExecBernard A. Fox, Ph.D · PORTLAND, ORExec · DirectorHong-Ming A. Hu, Ph.D · PORTLAND, ORExecBernard A. Fox, Mba · Portland, ORExecPenglin Wang · Chongqing, IsraelExec · DirectorDavid Moss · Chongqing, IsraelExecAdam R. Shaw · New York, NYExecKen Davenport · New York, NYExecCarlos A. Santiago · New York, NYExec · DirectorMohammad A. Sheikh · New York, NYExecFred F. Wang · New York, NYExecJason A. Hirsch · New York, NYExec

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗